60 related articles for article (PubMed ID: 15117581)
1. Relating glucose clamp profiles to reduction of blood glucose after insulin administration.
Woodworth JR; Howey DC; Bowsher RR; Brunelle RL
Diabetes Technol Ther; 2004 Apr; 6(2):147-53. PubMed ID: 15117581
[TBL] [Abstract][Full Text] [Related]
2. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
[TBL] [Abstract][Full Text] [Related]
3. Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase.
Vaughn DE; Yocum RC; Muchmore DB; Sugarman BJ; Vick AM; Bilinsky IP; Frost GI
Diabetes Technol Ther; 2009 Jun; 11(6):345-52. PubMed ID: 19459762
[TBL] [Abstract][Full Text] [Related]
4. Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin.
ter Braak EW; Woodworth JR; Bianchi R; Cerimele B; Erkelens DW; Thijssen JH; Kurtz D
Diabetes Care; 1996 Dec; 19(12):1437-40. PubMed ID: 8941480
[TBL] [Abstract][Full Text] [Related]
5. To: Scholtz HE, Pretorius SG, Wessels DH, Becker RHA (2005) Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia 48:1988-1995.
DeVries JH
Diabetologia; 2006 May; 49(5):1125-6. PubMed ID: 16520920
[No Abstract] [Full Text] [Related]
6. Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
Li J; Wang Y; Han L; Sun X; Yu H; Yu Y
Clin Ther; 2012 Dec; 34(12):2333-8. PubMed ID: 23195963
[TBL] [Abstract][Full Text] [Related]
7. Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans.
Davis SN; Shavers C; Costa F
J Clin Endocrinol Metab; 2000 Jun; 85(6):2148-57. PubMed ID: 10852444
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the steady-state pharmacokinetics and pharmacodynamics of a novel rapid-acting insulin analog, insulin glulisine, and regular human insulin in healthy volunteers using the euglycemic clamp technique.
Becker RH; Frick AD; Burger F; Scholtz H; Potgieter JH
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):292-7. PubMed ID: 15926116
[TBL] [Abstract][Full Text] [Related]
10. U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.
Heinemann L; Nosek L; Flacke F; Albus K; Krasner A; Pichotta P; Heise T; Steiner S
Diabetes Obes Metab; 2012 Mar; 14(3):222-7. PubMed ID: 21981286
[TBL] [Abstract][Full Text] [Related]
11. AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics.
de la Peña A; Seger M; Rave K; Heinemann L; Silverman B; Muchmore DB
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S75-80. PubMed ID: 19772452
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of the glucagon-like peptide-1 analog exenatide extended-release in healthy cats.
Rudinsky AJ; Adin CA; Borin-Crivellenti S; Rajala-Schultz P; Hall MJ; Gilor C
Domest Anim Endocrinol; 2015 Apr; 51():78-85. PubMed ID: 25594949
[TBL] [Abstract][Full Text] [Related]
13. Oral glucose augments the counterregulatory hormone response during insulin-induced hypoglycemia in humans.
Heptulla RA; Tamborlane WV; Ma TY; Rife F; Sherwin RS
J Clin Endocrinol Metab; 2001 Feb; 86(2):645-8. PubMed ID: 11158023
[TBL] [Abstract][Full Text] [Related]
14. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
15. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
Burge MR; Waters DL; Holcombe JH; Schade DS
J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Egan JM; Meneilly GS; Habener JF; Elahi D
J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
[TBL] [Abstract][Full Text] [Related]
18. The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests.
Brehm A; Thomaseth K; Bernroider E; Nowotny P; Waldhäusl W; Pacini G; Roden M
J Clin Endocrinol Metab; 2006 Jun; 91(6):2272-8. PubMed ID: 16595595
[TBL] [Abstract][Full Text] [Related]
19. Reduction in intrasubject variability in the pharmacokinetic response to insulin after subcutaneous co-administration with recombinant human hyaluronidase in healthy volunteers.
Morrow L; Muchmore DB; Ludington EA; Vaughn DE; Hompesch M
Diabetes Technol Ther; 2011 Oct; 13(10):1039-45. PubMed ID: 21714645
[TBL] [Abstract][Full Text] [Related]
20. A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes.
Korsatko S; Glettler K; Olsen KJ; Wutte A; Bock G; Koehler G; Mader JK; Semlitsch B; Pieber TR
Diabetes Obes Metab; 2013 Mar; 15(3):241-5. PubMed ID: 23013357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
